Abstract
The oncofertility information gap is caused by insufficient patient education on the effects of cancer treatment on fertility and the option of fertility preservation. Many cancer patients do not recall ever discussing the impact of cancer treatment on fertility with their oncologist; because of this, multidisciplinary care that includes fertility treatment is especially valuable for bridging the information gap. Genetic counselors—who are specifically trained to deliver options and facilitate decision making while also focusing on psychosocial issues—are an untapped resource for educating cancer patients about fertility impairment and fertility preservation options. Genetic counselors use a nondirective counseling approach to facilitate a shared decision-making process with patients. Additionally, genetic counselors provide emotional support and can assess when to make a mental health referral. Genetic counselors believe that fertility preservation discussions are important and a part of the genetic counselor role, yet the majority of cancer genetic counselors are not discussing fertility preservation or referring patients, often because of the timing of cancer treatment. A majority (79.7 %) of genetic counselors have reported that the number one barrier to discussing fertility preservation is seeing a patient after they have already undergone cancer treatment. If healthcare providers refer individuals who have a personal or family history suggestive of a hereditary or familial cancer prior to cancer treatment or prophylactic surgery, genetic counselors would have an opportunity to discuss fertility preservation with patients, thereby effectively bridging the oncofertility information gap.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
American Cancer Society. Cancer facts & figures 2013. Atlanta, GA: American Cancer Society; 2013.
Jeruss JS, Woodruff TK. Preservation of fertility in patients with cancer. N Engl J Med. 2009;360:902–11.
Hershberger PE, Finnegan L, Pierce PF, Scoccia B. The decision-making process of young adult women with cancer who considered fertility cryopreservation. J Obstet Gynecol Neonatal Nurs. 2013;42:59–69.
Yee S, Abrol K, McDonald M, Tonelli M, Liu KE. Addressing oncofertility needs: views of female cancer patients in fertility preservation. J Psychosoc Oncol. 2012;30:331–46.
Letourneau JM, Ebbel EE, Katz PP, Katz A, Ai WZ, Chien AJ, Melisko ME, Cedars MI, Rosen MP. Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer. Cancer. 2012;118:1710–7.
Kirkman M, Stern C, Neil S, Winship I, Mann GB, Shanahan K, Missen D, Shepherd H, Fisher JR. Fertility management after breast cancer diagnosis: a qualitative investigation of women’s experiences of and recommendations for professional care. Health Care Women Int. 2013;34:50–67.
Coccia PF, Altman J, Bhatia S, Borinstein SC, Flynn J, George S, Goldsby R, Hayashi R, Huang MS, Johnson RH, Beaupin LK, Link MP, Oeffinger KC, Orr KM, Pappo AS, Reed D, Spraker HL, Thomas DA, von Mehren M, Wechsler DS, Whelan KF, Zebrack BJ, Sundar H, Shead DA. Adolescent and young adult oncology. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2012;10:1112–50.
Peddie V, Porter M, Barbour R, Culligan D, MacDonald G, King D, Horn J, Bhattacharya S. Factors affecting decision making about fertility preservation after cancer diagnosis: a qualitative study. BJOG. 2012;119:1049–57.
Tschudin S, Bitzer J. Psychological aspects of fertility preservation in men and women affected by cancer and other life-threatening diseases. Hum Reprod Update. 2009;15:587–97.
Hayat Roshanai A, Lampic C, Ingvoldstad C, Askmalm MS, Bjorvatn C, Rosenquist R, Nordin K. What information do cancer genetic counselees prioritize? J Genet Couns. 2012;21:510–26.
Campfield Bonadies D, Moyer A, Matloff ET. What I wish I’d known before surgery: BRCA carriers’ perspectives after bilateral salipingo-oophorectomy. Fam Cancer. 2011;10:79–85.
Lee MC, Gray J, Han HS, Plosker S. Fertility and reproductive considerations in premenopausal patients with breast cancer. Cancer Control. 2010;17:162–72.
Bennett RL, Hampel HL, Mandell JB, Marks JH. Genetic counselors: translating genomic science into clinical practice. J Clin Invest. 2003;112:1274–9.
Uhlmann WR, Schuette JL, Yashar BM. A guide to genetic counseling. Hoboken, NJ: Wiley; 2009.
Weil J. Psychosocial genetic counseling. New York: Oxford University Press; 2000.
Veach PM, LeRoy BS, Bartels DM. Facilitating the genetic counseling process: a practice manual. New York: Springer; 2003.
Clayman ML, Galvin KM, Arntson P. Shared decision making: fertility and pediatric cancers. In: Woodruff TK, Snyder KA, editors. Oncofertility. New York: Springer Science + Business Media, LLC.; 2007.
Elwyn G, Gray J, Clarke A. Shared decision making and non-directiveness in genetic counselling. J Med Genet. 2000;37:135–8.
Volk A, Aufox S, Fallen T, Beaumont J, Woodruff TK. Genetic Counselor attitudes, knowledge, and discussions of fertility preservation in the hereditary breast and ovarian cancer clinic. [unpublished manuscript]; 2012.
Berliner JL, Fay AM. Practice Issues Subcommittee of the National Society of Genetic Counselors’ Familial Cancer Risk Counseling Special Interest G. Risk assessment and genetic counseling for hereditary breast and ovarian cancer: recommendations of the National Society of Genetic Counselors. J Genet Couns. 2007;16:241–60.
Wevers MR, Hahn DE, Verhoef S, Bolhaar MD, Ausems MG, Aaronson NK, Bleiker EM. Breast cancer genetic counseling after diagnosis but before treatment: a pilot study on treatment consequences and psychological impact. Patient Educ Couns. 2012;89:89–95.
Miesfeldt S, Lamb A, Duarte C. Management of genetic syndromes predisposing to gynecologic cancers. Curr Treat Options Oncol. 2013;14:34–50.
Domchek SM, Friebel TM, Neuhausen SL, Wagner T, Evans G, Isaacs C, Garber JE, Daly MB, Eeles R, Matloff E, Tomlinson GE, Van’t Veer L, Lynch HT, Olopade OI, Weber BL, Rebbeck TR. Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study. Lancet Oncol. 2006;7:223–9.
Quinn G, Vadaparampil S, Wilson C, King L, Choi J, Miree C, Friedman S. Attitudes of high-risk women toward preimplantation genetic diagnosis. Fertil Steril. 2009;91:2361–8.
Shulman LP, Dungan JS. Cancer genetics: risks and mechanisms of cancer in women with inherited susceptibility to epithelial ovarian cancer. In: Woodruff TK, Zoloth L, Campo-Engelstein L, Rodriguez S, editors. Oncofertility ethical, legal, social, and medical perspectives. New York: Springer Science + Business Media, LLC.; 2010.
Acknowledgements
This work was supported by the Oncofertility Consortium NIH 5UL1DE019587 and the Specialized Cooperative Centers Program in Reproduction and Infertility Research NIH U54HD076188.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Goetsch, A., Volk, A., Woodruff, T.K. (2014). Genetic Counselors: Bridging the Oncofertility Information Gap. In: Woodruff, T., Clayman, M., Waimey, K. (eds) Oncofertility Communication. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8235-2_7
Download citation
DOI: https://doi.org/10.1007/978-1-4614-8235-2_7
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-8234-5
Online ISBN: 978-1-4614-8235-2
eBook Packages: MedicineMedicine (R0)